Targeting miR-21 to treat psoriasis

Area of Science:

• Dermatology
• Molecular Biology
• Immunology

Background:

• Psoriasis is a common inflammatory skin condition with complex pathogenesis.
• MicroRNAs (miRNAs) regulate gene expression and are implicated in various diseases.
• While some miRNAs are upregulated in psoriasis, their causal role remains unclear.

Purpose of the Study:

• To investigate the functional role of miR-21 in psoriasis pathogenesis.
• To explore the therapeutic potential of targeting miR-21 in psoriasis.

Main Methods:

• Confirmed increased miR-21 expression in psoriatic lesions.
• Utilized patient-derived skin samples and mouse models of psoriasis.
• Administered locked nucleic acid (LNA)-modified anti-miR-21 compounds.

Main Results:

• Increased miR-21 led to reduced tissue inhibitor of matrix metalloproteinase 3 (TIMP-3) and activation of TACE/ADAM17.
• miR-21 upregulation was linked to impaired Jun/activating protein 1 (AP-1) activity and activation of the IL-6/Stat3 pathway.
• Inhibition of miR-21 ameliorated disease pathology in both xenotransplant and mouse models.

Conclusions:

• Increased miR-21 expression is a key factor in psoriasis development.
• Targeting miR-21 with anti-miR-21 compounds shows therapeutic promise for psoriasis treatment.